Patents by Inventor Frank Everaerts

Frank Everaerts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070087059
    Abstract: Bioactive delivery matrix compositions and methods of making and using such compositions.
    Type: Application
    Filed: October 17, 2005
    Publication date: April 19, 2007
    Inventors: Frank Everaerts, Marc Hendriks, Mirian Gillissen
  • Publication number: 20070020248
    Abstract: The present invention provides an electrophoretic system, apparatus, and method of use thereof for the preparation of a tissue-derived bioprosthesis.
    Type: Application
    Filed: March 1, 2006
    Publication date: January 25, 2007
    Inventors: Frank Everaerts, Mark Torrianni, Frans Everaerts, Paul Trescony, Wilfred Hartog
  • Publication number: 20060257449
    Abstract: The present invention is directed to methods, compositions, systems, and medical devices for fusing bone.
    Type: Application
    Filed: May 16, 2005
    Publication date: November 16, 2006
    Inventors: Didier Billy, Frank Everaerts, Michel Verhoeven
  • Patent number: 7053051
    Abstract: Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: May 30, 2006
    Assignee: Medtronic, Inc.
    Inventors: Marc Hendriks, Frank Everaerts, Mirian Gillissen, Michel Verhoeven, Mark W. Torrianni
  • Publication number: 20050136510
    Abstract: Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.
    Type: Application
    Filed: October 27, 2004
    Publication date: June 23, 2005
    Inventors: Marc Hendriks, Frank Everaerts, Mirian Gillissen, Michel Verhoeven, Mark Torrianni
  • Publication number: 20050020506
    Abstract: A composition comprising a collagen protein and demineralized bone matrix is described wherein the composition is chemically cross-linked with a carbodiimide such as N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC). The crosslinking reaction can be conducted in the presence of N-hydroxysuccinimide (NHS). The collagen can be in a porous matrix or scaffolding. The DBM can be in the form of particles dispersed in the collagen. A method of making the composition is also described wherein a collagen slurry is cast into the desired shape, freeze dried to form a porous scaffolding and infitrated with a solution comprising the cross-linking agent. The composition can be used as an implant for tissue (e.g., soft tissue or bone) engineering.
    Type: Application
    Filed: July 25, 2003
    Publication date: January 27, 2005
    Inventors: Susan Drapeau, Mark Torrianni, Frank Everaerts, William McKay